Cefuroxime Axetil

PharmAlliance International Labs introduces the Cefuroxime Axetil Range, advancing bacterial infection management. Explore second-generation potency with Cefuroxime, targeting a broad spectrum of bacteria. Versatile formulations, including oral suspension options, cater to diverse patient needs. Experience convenience with thoughtful packing specifications, enhancing patient compliance. Embark on a journey of excellence, redefining healthcare solutions for a brighter, healthier tomorrow.



Empowering Healthcare with PharmAlliance’s Cefuroxime Axetil Range

Welcome to PharmAlliance International Labs Private Limited, where excellence meets innovation in pharmaceuticals. Embark on a journey towards effective bacterial infection management with our esteemed Cefuroxime Axetil Range, meticulously crafted to address the diverse needs of healthcare professionals worldwide.

Unveiling Second-Generation Potency:

Cefuroxime Axetil, a cornerstone of our antibiotic arsenal, belongs to the esteemed class of second-generation cephalosporins. Celebrated for their broad-spectrum activity against both Gram-positive and Gram-negative bacteria, Cefuroxime Axetil epitomizes our dedication to superior infection management.

Comprehensive Formulations for Optimal Flexibility:

Explore our versatile range of formulations tailored to cater to varying patient requirements:

Cefuroxime 125mg/5ml Oral Suspension (DS): Each 5ml of oral suspension delivers 125mg of Cefuroxime Axetil, providing a convenient and palatable option tailored for pediatric patients.

Cefuroxime 250mg/5ml Oral Suspension (DS): Offering a higher dosage option, each 5ml of oral suspension contains 250mg of Cefuroxime, catering to pediatric patients and adults requiring increased strength.

Pharmacokinetics and Pharmacodynamics Unveiled:

Delve into the intricate pharmacological dynamics of Cefuroxime:

Pharmacokinetics: Rapid oral absorption coupled with urinary excretion characterizes Cefuroxime’s pharmacokinetic profile, ensuring swift therapeutic action.

Pharmacodynamics: By disrupting bacterial cell wall synthesis, Cefuroxime unleashes its bactericidal prowess, effectively combating a broad spectrum of Gram-positive and Gram-negative bacteria.

Indications Reflecting Versatility:

From upper respiratory tract infections to Lyme disease, our Cefuroxime Range stands poised to tackle a myriad of bacterial infections with precision and efficacy.

Optimized Usage and Dosage Guidelines:

Navigate the labyrinth of dosing with confidence:

Usage: Administer orally with or without food, adhering to healthcare provider instructions for optimal therapeutic outcomes.

Dosage: Tailored dosages ensure personalized treatment regimens, accounting for infection type, severity, and patient-specific factors.

Thoughtful Packing Specifications:

Experience convenience and efficacy seamlessly integrated:

Cefuroxime Oral Suspension (DS): Presented in 50ml bottles, our oral suspension ensures an ample supply for the prescribed treatment duration, enhancing patient compliance.

Unveiling Side Effect Profile:

While generally well-tolerated, vigilance against potential adverse effects ensures patient safety:

Common Side Effects: Diarrhea, nausea, and vomiting may occur, warranting cautious monitoring.

Rare Adverse Effects: Allergic reactions and pseudomembranous colitis, though infrequent, necessitate prompt medical attention.

Embark on a Journey of Excellence:

Experience the epitome of reliability and effectiveness with PharmAlliance International Labs Private Limited’s Cefuroxime Range. For further inquiries and information, we invite you to connect with us as we redefine healthcare solutions for a brighter, healthier tomorrow.


There are no reviews yet.

Be the first to review “Cefuroxime Axetil”

Your email address will not be published. Required fields are marked *

Pharmalliance.pkĀ© 2024. All rights reserved. Terms of use and Privacy Policy